MBD5 and nasopharyngeal carcinoma: CMAs of each NPC line were consistent with fibroblast and iPSC analyses, and RT-qPCR studies confirmed significantly reduced MBD5 mRNA expression in the MAND-NPC lines (Fig. 2d).